Clinical Management of Presumptive Effusive Feline Infectious Peritonitis in a Seven-Month-Old Kitten with Concurrent Feline Panleukopenia and Giardiasis: Diagnostic Evaluation, Antiviral Therapy, and Follow-up

  • Post last modified:
  • Reading time:7 mins read

A SWOLLEN BELLY, A FRAIL KITTEN, AND THREE SERIOUS MEDICAL CONCERNS

A swollen abdomen might make a kitten appear well-fed or even overweight. But what happens when the belly keeps getting bigger while the rest of the body becomes alarmingly thin?

This was the concerning condition of a seven-month-old Persian kitten brought to Aycardo Veterinary Center Inc. (AVCI) – Mandaue Branch.

Weighing only 1.40 kilograms, the kitten was severely underweight despite having a noticeably distended abdomen. Her abdominal circumference measured approximately 34 centimeters.

Further diagnostic examinations revealed something more serious than ordinary abdominal bloating: abnormal fluid accumulation within the abdominal cavity, accompanied by laboratory findings strongly suggestive of Feline Infectious Peritonitis (FIP).

And that wasn’t the only medical concern.

The kitten also tested positive for Feline Panleukopenia Virus (FPV) and Giardia, making this a particularly complex case requiring careful diagnostic assessment and individualized medical management.

Understanding Effusive FIP: Why Fluid Accumulates Inside the Abdomen

Feline Infectious Peritonitis is a serious inflammatory disease associated with feline coronavirus (FCoV).

Although feline coronavirus infection is relatively common among cats, only a proportion of infected animals develop FIP.

The disease involves an abnormal inflammatory response that can affect blood vessels and various internal organs.

In the effusive form of FIP, sometimes called wet FIP, inflammation affecting small blood vessels contributes to leakage of protein-rich fluid into body cavities, particularly the abdomen or chest.

This fluid accumulation is known as an effusion.

When it develops inside the abdomen, it is called ascites.

As fluid accumulates, the abdomen may become progressively enlarged, even while the affected cat experiences significant weight loss, poor appetite, weakness, or deteriorating body condition.

This explains how a kitten can appear to have a large belly while actually being severely underweight.

The Diagnostic Challenge: Why FIP Cannot Be Determined by One Test Alone

Because several diseases can cause abdominal fluid accumulation, diagnosing FIP requires careful interpretation of the patient’s clinical signs, laboratory findings, and fluid characteristics.

In this case, blood examinations revealed several abnormalities:

  • Mild anemia: A reduction in red blood cells or hemoglobin, potentially affecting the blood’s oxygen-carrying capacity.
  • Marked thrombocytopenia: A decreased platelet count. Platelets are important for normal blood clotting.
  • Hypoalbuminemia: A reduced concentration of albumin, a major blood protein that helps maintain fluid balance within blood vessels.
  • Mildly elevated alkaline phosphatase (ALP): A biochemical finding that may occur with several hepatobiliary or other physiological conditions.

The albumin-to-globulin (A) ratio, another parameter considered during FIP evaluation, remained within the laboratory reference range but showed a downward trend.

Additional screening detected feline coronavirus antigen and antibodies reported by the test as FIP-related.

However, positive coronavirus screening results alone cannot establish a definitive diagnosis of FIP, because coronavirus exposure or infection does not necessarily mean that a cat has developed FIP.

A particularly important part of the evaluation involved examining the accumulated abdominal fluid.

The fluid demonstrated increased protein concentration and nucleated cell counts, while the Rivalta test returned a positive result.

The Rivalta test is a screening procedure used to evaluate whether abdominal fluid has characteristics associated with inflammation and elevated protein content. A positive result can support suspicion of FIP, but it is not specific to the disease.

Taken together, the clinical presentation, blood abnormalities, fluid characteristics, and screening results raised strong suspicion for effusive FIP.

The diagnosis remained presumptive rather than definitively confirmed.

Three Medical Concerns in One Kitten

Aside from presumptive FIP, the kitten had positive screening results for two additional infectious agents.

Feline Panleukopenia Virus (FPV)

Feline panleukopenia, sometimes called feline distemper, is a highly contagious viral disease that particularly affects kittens.

The virus targets rapidly dividing cells, including those in the intestinal lining and bone marrow. Severe infections may cause vomiting, diarrhea, dehydration, and suppression of normal white blood cell production.

Giardiasis

Giardiasis is an intestinal infection caused by Giardia, a microscopic protozoan parasite.

The organism can interfere with normal intestinal function and nutrient absorption, sometimes causing diarrhea, weight loss, and poor body condition.

The coexistence of these positive findings made the patient’s overall condition particularly concerning.

With multiple possible contributors to illness, medical management needed to consider not only the suspected FIP but also the kitten’s nutritional status, gastrointestinal health, hydration, and laboratory abnormalities.

Treatment: Addressing the Fluid Accumulation and Underlying Medical Conditions

Given the kitten’s condition, hospitalization and individualized medical management were initiated.

One of the initial procedures was abdominocentesis, in which a needle or catheter is introduced into the abdominal cavity to collect accumulated fluid for diagnostic evaluation or therapeutic relief.

Approximately 192 milliliters of abdominal fluid were removed, reducing the measured abdominal circumference from 34 centimeters to 28 centimeters.

While this procedure helped relieve abdominal distension and provided valuable diagnostic information, fluid removal itself does not eliminate the underlying disease responsible for the effusion.

The treatment plan therefore included antiviral therapy directed toward the suspected FIP.

The kitten initially received injectable GS-441524, an antiviral compound that inhibits coronavirus RNA replication.

Following the initial injectable treatment period, the patient transitioned to a prescribed oral antiviral combination containing GS-441524 and EIDD-1931, with an intended treatment course of 84 days.

This represented an important part of the overall management strategy.

Historically, FIP was considered an almost invariably fatal disease. However, advances in antiviral therapy, particularly GS-441524-based treatment, have substantially improved the prognosis for many affected cats.

Treatment still requires careful veterinary supervision, appropriate drug selection, and monitoring of clinical and laboratory responses.

In addition to antiviral management, the kitten received supportive treatment addressing gastrointestinal concerns, nutritional deficiencies, hydration, appetite, and other clinical needs.

Nutritional support was especially important because the patient entered treatment in a severely underweight condition.

Encouraging Progress: From Severe Weakness to Eating Independently

Despite the seriousness of the initial presentation, the kitten began showing encouraging clinical improvement.

By the second day of hospitalization, she was becoming more responsive and had started eating voluntarily.

This was an important clinical development, particularly in a patient whose poor body condition and concurrent illnesses made nutritional support a major concern.

Following discharge, the owner elected to continue the prescribed treatment at home under veterinary guidance.

A subsequent follow-up report provided another encouraging update.

More than two months after her initial admission, the kitten was reportedly eating well, and no recurrence of abdominal fluid accumulation had been observed.

At that time, she was still undergoing her prescribed antiviral treatment.

Although the improvement was promising, the absence of recurrent abdominal swelling alone does not establish complete remission or a definitive cure.

Continued treatment, veterinary reassessment, and laboratory monitoring remain important for evaluating therapeutic response and detecting possible complications or relapse.

What Pet Owners Should Learn from This Case

One of the most important lessons from this case is that a swollen belly does not always mean weight gain, overeating, or intestinal worms.

In some cats, abdominal enlargement may result from fluid accumulation associated with serious systemic disease.

It also demonstrates why diagnostic testing is essential.

Without further evaluation, it would have been difficult to distinguish ordinary abdominal bloating from an inflammatory effusion, much less identify the additional infectious concerns present in this kitten.

For cats suspected of having FIP, veterinary assessment is particularly important because treatment decisions depend on the overall clinical picture rather than any single screening result.

The introduction of effective antiviral therapies has provided new possibilities for patients affected by this once-devastating disease. Nevertheless, individual responses vary, and treatment requires commitment, monitoring, and appropriate medical guidance.

For this kitten, comprehensive diagnostic evaluation, antiviral treatment, supportive medical care, and continued home management were associated with encouraging clinical improvement.

At AVCI, treating a complex medical condition involves more than addressing the most obvious symptom. It means investigating the underlying disease processes, recognizing concurrent health concerns, and developing an individualized treatment plan suited to the patient’s needs.

Case handled by Dr. Maria Bienessa L. Gatela.

Picture of Dr. Maria Bienessa L. Gatela

Dr. Maria Bienessa L. Gatela

Attending Veterinarian